Matches in SemOpenAlex for { <https://semopenalex.org/work/W954655434> ?p ?o ?g. }
- W954655434 endingPage "1160" @default.
- W954655434 startingPage "1153" @default.
- W954655434 abstract "C3 glomerulonephritis is a clinicopathologic entity defined by the presence of isolated or dominant deposits of C3 on immunofluorescence. To explore the effect of immunosuppression on C3 glomerulonephritis, we studied a series of 60 patients in whom a complete registry of treatments was available over a median follow-up of 47 months. Twenty patients had not received immunosuppressive treatments. In the remaining 40 patients, 22 had been treated with corticosteroids plus mycophenolate mofetil while 18 were treated with other immunosuppressive regimens (corticosteroids alone or corticosteroids plus cyclophosphamide). The number of patients developing end-stage renal disease was significantly lower among treated compared with untreated patients (3 vs. 7 patients, respectively). No patient in the corticosteroids plus mycophenolate mofetil group doubled serum creatinine nor developed end-stage renal disease, as compared with 7 (significant) and 3 (not significant), respectively, in patients treated with other immunosuppressive regimens. Renal survival (100, 80, and 72% at 5 years) and the number of patients achieving clinical remission (86, 50, and 25%) were significantly higher in patients treated with corticosteroids plus mycophenolate mofetil as compared with patients treated with other immunosuppressive regimens and untreated patients, respectively. Thus, immunosuppressive treatments, particularly corticosteroids plus mycophenolate mofetil, can be beneficial in C3 glomerulonephritis." @default.
- W954655434 created "2016-06-24" @default.
- W954655434 creator A5000252616 @default.
- W954655434 creator A5000722599 @default.
- W954655434 creator A5001450021 @default.
- W954655434 creator A5001860787 @default.
- W954655434 creator A5003429051 @default.
- W954655434 creator A5013004552 @default.
- W954655434 creator A5015402051 @default.
- W954655434 creator A5018160190 @default.
- W954655434 creator A5024051115 @default.
- W954655434 creator A5024530998 @default.
- W954655434 creator A5025647390 @default.
- W954655434 creator A5030567793 @default.
- W954655434 creator A5032703651 @default.
- W954655434 creator A5037815109 @default.
- W954655434 creator A5038856959 @default.
- W954655434 creator A5042551332 @default.
- W954655434 creator A5046852623 @default.
- W954655434 creator A5050383563 @default.
- W954655434 creator A5052017202 @default.
- W954655434 creator A5052276722 @default.
- W954655434 creator A5055840067 @default.
- W954655434 creator A5061394221 @default.
- W954655434 creator A5062709094 @default.
- W954655434 creator A5064242884 @default.
- W954655434 creator A5070761001 @default.
- W954655434 creator A5070978722 @default.
- W954655434 creator A5077324980 @default.
- W954655434 creator A5078848450 @default.
- W954655434 creator A5084620426 @default.
- W954655434 creator A5086263807 @default.
- W954655434 creator A5088922534 @default.
- W954655434 date "2015-11-01" @default.
- W954655434 modified "2023-10-15" @default.
- W954655434 title "Effectiveness of mycophenolate mofetil in C3 glomerulonephritis" @default.
- W954655434 cites W1964816580 @default.
- W954655434 cites W1971659350 @default.
- W954655434 cites W1977818941 @default.
- W954655434 cites W1981285680 @default.
- W954655434 cites W1984900914 @default.
- W954655434 cites W1993590923 @default.
- W954655434 cites W2021435063 @default.
- W954655434 cites W2021988356 @default.
- W954655434 cites W2030887980 @default.
- W954655434 cites W2046427044 @default.
- W954655434 cites W2047093719 @default.
- W954655434 cites W2056763841 @default.
- W954655434 cites W2063874378 @default.
- W954655434 cites W2070909069 @default.
- W954655434 cites W2071219763 @default.
- W954655434 cites W2074855979 @default.
- W954655434 cites W2076848429 @default.
- W954655434 cites W2077144266 @default.
- W954655434 cites W2077994995 @default.
- W954655434 cites W2079140345 @default.
- W954655434 cites W2081522308 @default.
- W954655434 cites W2107516496 @default.
- W954655434 cites W2108666080 @default.
- W954655434 cites W2108858161 @default.
- W954655434 cites W2116085004 @default.
- W954655434 cites W2118510193 @default.
- W954655434 cites W2119057191 @default.
- W954655434 cites W2119837784 @default.
- W954655434 cites W2126092981 @default.
- W954655434 cites W2126299539 @default.
- W954655434 cites W2138581004 @default.
- W954655434 cites W2139585104 @default.
- W954655434 cites W2143620060 @default.
- W954655434 cites W2151241196 @default.
- W954655434 cites W2157232297 @default.
- W954655434 cites W2162002618 @default.
- W954655434 cites W2167821466 @default.
- W954655434 doi "https://doi.org/10.1038/ki.2015.227" @default.
- W954655434 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26221755" @default.
- W954655434 hasPublicationYear "2015" @default.
- W954655434 type Work @default.
- W954655434 sameAs 954655434 @default.
- W954655434 citedByCount "119" @default.
- W954655434 countsByYear W9546554342016 @default.
- W954655434 countsByYear W9546554342017 @default.
- W954655434 countsByYear W9546554342018 @default.
- W954655434 countsByYear W9546554342019 @default.
- W954655434 countsByYear W9546554342020 @default.
- W954655434 countsByYear W9546554342021 @default.
- W954655434 countsByYear W9546554342022 @default.
- W954655434 countsByYear W9546554342023 @default.
- W954655434 crossrefType "journal-article" @default.
- W954655434 hasAuthorship W954655434A5000252616 @default.
- W954655434 hasAuthorship W954655434A5000722599 @default.
- W954655434 hasAuthorship W954655434A5001450021 @default.
- W954655434 hasAuthorship W954655434A5001860787 @default.
- W954655434 hasAuthorship W954655434A5003429051 @default.
- W954655434 hasAuthorship W954655434A5013004552 @default.
- W954655434 hasAuthorship W954655434A5015402051 @default.
- W954655434 hasAuthorship W954655434A5018160190 @default.
- W954655434 hasAuthorship W954655434A5024051115 @default.
- W954655434 hasAuthorship W954655434A5024530998 @default.